Overview

A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Nerandomilast in the Blood

Status:
COMPLETED
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to investigate the effect of carbamazepine on pharmacokinetics of nerandomilast.
Phase:
PHASE1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Carbamazepine